Advances in personalized radiotherapy.

Humans Precision Medicine / methods Neoplasms / radiotherapy Radiotherapy / methods Treatment Outcome

Journal

BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800

Informations de publication

Date de publication:
03 May 2024
Historique:
received: 13 10 2023
accepted: 29 04 2024
medline: 4 5 2024
pubmed: 4 5 2024
entrez: 3 5 2024
Statut: epublish

Résumé

Radiotherapy is a mainstay of cancer treatment. The clinical response to radiotherapy is heterogeneous, from a complete response to early progression. Recent studies have explored the importance of patient characteristics in response to radiotherapy. In this editorial, we invite contributions for a BMC Cancer collection of articles titled 'Advances in personalized radiotherapy' towards the improvement of treatment response.

Identifiants

DOI: 10.1186/s12885-024-12317-3 PMID: 38702617
pubmed: 38702617
doi: 10.1186/s12885-024-12317-3
pii: 10.1186/s12885-024-12317-3
doi:

Types de publication

Editorial Introductory Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

556

Informations de copyright

© 2024. The Author(s).

Références

Trapani D, Franzoi MA, Burstein HJ, Carey LA, Delaloge S, Harbeck N, et al. Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification. Ann Oncol. 2022;33(7):702–12.
doi: 10.1016/j.annonc.2022.03.273 pubmed: 35550723
Behnam B, Taghizadeh-Hesary F. Mitochondrial metabolism: a New Dimension of Personalized Oncology. Cancers. 2023;15(16):4058.
doi: 10.3390/cancers15164058 pubmed: 37627086 pmcid: 10452105
Whelan TJ, Smith S, Nielsen TO, Parpia S, Fyles AW, Bane A, et al. LUMINA: a prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC). J Clin Oncol. 2022;40(17suppl):LBA501–LBA.
doi: 10.1200/JCO.2022.40.17_suppl.LBA501
Gogineni K, Kalinsky K. Individualizing adjuvant therapy in women with hormone Receptor–Positive, human epidermal growth factor receptor 2–Negative node-positive breast Cancer. JCO Oncol Pract. 2022;18(4):247–51.
doi: 10.1200/OP.21.00780 pubmed: 35108074
Heidinger M, Maggi N, Dutilh G, Mueller M, Eller RS, Loesch JM, et al. Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital. World J Surg Oncol. 2023;21(1):176.
doi: 10.1186/s12957-023-03062-1 pubmed: 37287038 pmcid: 10249276
Overgaard J, Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, et al. Personalised radiation therapy taking both the tumour and patient into consideration. Radiother Oncol. 2022;166:A1–5.
doi: 10.1016/j.radonc.2022.01.010 pubmed: 35051440
Osapoetra LO, Dasgupta A, DiCenzo D, Fatima K, Quiaoit K, Saifuddin M, et al. Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics. Sci Rep. 2021;11(1):6117.
doi: 10.1038/s41598-021-85221-6 pubmed: 33731738 pmcid: 7969626
Manem VS, Dhawan A. RadiationGeneSigDB: a database of oxic and hypoxic radiation response gene signatures and their utility in pre-clinical research. Br J Radiol. 2019;92(1103):20190198.
doi: 10.1259/bjr.20190198 pubmed: 31538514 pmcid: 6849679
Manem VSK. Development and validation of genomic predictors of radiation sensitivity using preclinical data. BMC Cancer. 2021;21(1):937.
doi: 10.1186/s12885-021-08652-4 pubmed: 34416855 pmcid: 8377977
Manem VSK, Dhawan A. Modelling recurrence and second cancer risks induced by proton therapy. Math Med Biol. 2018;35(3):347–61.
doi: 10.1093/imammb/dqx006 pubmed: 29106564
Wen S, Ovais M, Li X, Ren J, Liu T, Wang Z, et al. Tailoring bismuth-based nanoparticles for enhanced radiosensitivity in cancer therapy. Nanoscale. 2022;14(23):8245–54.
doi: 10.1039/D2NR01500E pubmed: 35647806
Taghizadeh-Hesary F. “Reinforcement” by tumor microenvironment: the seventh “R” of radiobiology. Int J Radiat Oncol Biol Phys. 2023;25:S0360-3016(23)07940-3. https://doi.org/10.1016/j.ijrobp.2023.09.027 . Epub ahead of print. PMID: 38032584.
Taghizadeh-Hesary F, Houshyari M, Farhadi M. Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity. J Cancer Res Clin Oncol. 2023.
Avril D, Foy JP, Bouaoud J, Grégoire V, Saintigny P. Biomarkers of radioresistance in head and neck squamous cell carcinomas. Int J Radiat Biol. 2023;99(4):583–93.
doi: 10.1080/09553002.2022.2110301 pubmed: 35930497
Li Z, Zhang Y, Hong W, Wang B, Chen Y, Yang P, et al. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling. Gut Microbes. 2022;14(1):2119055.
doi: 10.1080/19490976.2022.2119055 pubmed: 36093568 pmcid: 9467592

Auteurs

Venkata Sk Manem (VS)

Centre de Recherche du CHU de Québec - Université Laval, Quebec, Canada.
Department of Mathematics and Computer Science, University of Quebec at Trois-Rivières, Quebec, Canada.

Farzad Taghizadeh-Hesary (F)

ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. farzadth89@gmail.com.
Department of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran. farzadth89@gmail.com.
ORCID: 0000-0002-6195-2203

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Advances in personalized radiotherapy.
questionsmedicales.fr › Professions de santé › Médecine › Médecine clinique › Médecine de précision › Advances in personalized radiotherapy.
questionsmedicales.fr › Tumeurs › Advances in personalized radiotherapy.
questionsmedicales.fr › Thérapeutique › Radiothérapie › Advances in personalized radiotherapy.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Advances in personalized radiotherapy.